GREYSCALING
Regulatory consulting for drug development
DIANE SHODA
Experience and insight to drive scale and enhance outcomes
Program assessment to evaluate regulatory pathways
Risk mitigation strategy development
Planning and execution of meeting with regulators
Second opinion on feedback from regulators
Due diligence for licensing candidates
Collaborative consulting for your drug development journey
